Sanders Rejects Latest EpiPen Discount Move as Inadequate
Former Democratic presidential contender Sen. Bernie Sanders criticized pharmaceutical company Mylan for raising the cost of their EpiPens to over $600 for a pack of two.
The Hill reports:
Sen. Bernie Sanders (I-Vt.) is denouncing the maker of EpiPens for not going far enough in addressing complaints over its sharply rising price.
Mylan announced earlier Monday that it would offer a generic version of the treatment for serious allergic reactions at a cost of $300 for a pack of two, less than half the current cost.
But Sanders said even that cost was still a dramatic increase in recent years, and “shameful.”
Sanders has made fighting high drug prices a major issue, and his former rival for the Democratic presidential nomination, Hillary Clinton, has also called on Mylan to lower its price.
Republicans have also expressed outrage at Mylan’s prices, but have pointed to faster approvals of generic competitors by the Food and Drug Administration as a potential solution.
House Energy and Commerce Committee Chairman Fred Upton (R-Mich.) wrote to the FDA asking about the review process for approving generic competitors.
Democrats, meanwhile, have called for ideas like allowing Medicare to negotiate drug prices.
Photo credit: CNN/Screenshot.